Srinivas Vourganti to Female
This is a "connection" page, showing publications Srinivas Vourganti has written about Female.
Connection Strength
0.119
-
Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2?years too long to wait? Nephrol Dial Transplant. 2017 Oct 01; 32(10):1767-1773.
Score: 0.046
-
The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols. Urol Oncol. 2017 04; 35(4):153.e15-153.e20.
Score: 0.011
-
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. Urol Oncol. 2015 Apr; 33(4):167.e13-20.
Score: 0.010
-
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb 10; 32(5):431-7.
Score: 0.009
-
Estrogen receptor-? expression and pharmacological targeting in bladder cancer. Oncol Rep. 2013 Jul; 30(1):131-8.
Score: 0.008
-
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014 Jan; 32(1):23.e9-13.
Score: 0.008
-
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol. 2012 Dec; 188(6):2084-8.
Score: 0.008
-
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012 Jun; 109(11):1600-6.
Score: 0.008
-
Laparoendoscopic single-site nephrectomy: initial clinical experience in children. J Endourol. 2010 Dec; 24(12):1957-61.
Score: 0.007
-
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration. Blood. 2002 Oct 01; 100(7):2341-8.
Score: 0.004